| Stem definition | Drug id | CAS RN |
|---|---|---|
| tricyclic compounds | 383 | 5802-61-9 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
None
None
None
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Haemolytic uraemic syndrome | 65.18 | 53.84 | 11 | 160 | 2275 | 34954485 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Haemolytic uraemic syndrome | 55.19 | 39.88 | 11 | 476 | 4438 | 79739463 |
| Cytokine release syndrome | 53.08 | 39.88 | 16 | 471 | 35982 | 79707919 |
| COVID-19 pneumonia | 43.26 | 39.88 | 13 | 474 | 28836 | 79715065 |
| Embolic pneumonia | 40.61 | 39.88 | 5 | 482 | 85 | 79743816 |
None
None
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.66 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Histamine H1 receptor | GPCR | ANTAGONIST | KEGG DRUG | KEGG DRUG |
| ID | Source |
|---|---|
| D07532 | KEGG_DRUG |
| 42504-83-6 | SECONDARY_CAS_RN |
| CHEBI:135277 | CHEBI |
| C0058491 | UMLSCUI |
| 6537425 | PUBCHEM_CID |
| 595726R32U | UNII |
None